Xenon Pharma appoints Andrea DiFabio as Chief Legal Officer and Corporate Secretary

Xenon Pharmaceuticals Inc.

Andrea DiFabio joined Xenon as Chief Legal Officer and Corporate Secretary effective Nov 7, 2022.
She previously served as Chief Legal & Admin Officer at Repertoire Immune Medicines (2020-2022).
DiFabio held CLO roles at Codiak Biosciences and Bioverativ; earlier experience at Biogen and Parexel.
She will lead global legal strategy as Xenon advances late-stage epilepsy clinical programs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.